December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Alterations in Arachidonic Acid (AA) Release, Inostil Phosphates Formation and Phospholipase C-beta1 (PLC-beta1) Expression in Glaucomatous Human Ciliary Muscle (HCM) Cells
Author Affiliations & Notes
  • S Husain
    Biochemistry & Molecular Biology
    Medical College of Georgia Augusta GA
  • I Kaddour-Djebbar
    Biochemistry and Molecular Biology
    Medical College of Georgia Augusta GA
  • AA Abdel-Latif
    Biochemistry and Molecular Biology
    Medical College of Georgia Augusta GA
  • Footnotes
    Commercial Relationships   S. Husain, None; I. Kaddour-Djebbar, None; A.A. Abdel-Latif, None. Grant Identification: Support: NIH Grants R01-EY-04171 and R01-EY-04387
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 3269. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S Husain, I Kaddour-Djebbar, AA Abdel-Latif; Alterations in Arachidonic Acid (AA) Release, Inostil Phosphates Formation and Phospholipase C-beta1 (PLC-beta1) Expression in Glaucomatous Human Ciliary Muscle (HCM) Cells . Invest. Ophthalmol. Vis. Sci. 2002;43(13):3269.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:Prostaglandin F2alpha (PGF2alpha ) as well as other Ca2+-mobilizing agonists, such as carbachol (CCh) and endothelin-1 (ET-1), induce an increase in uveoscleral outflow in part through receptor -mediated mechanisms in the ciliary muscle. Since changes in uveoscleral outflow across the ciliary muscle could cause elevation of intraocular pressure (IOP) in glaucoma patients, the purpose of the present study was to investigate the possibility that agonist-induced second messenger generation may be altered in glaucomatous HCM (g-HCM) cells as compared to normal HCM (n-HCM) cells. Methods:[3H] AA release was measured by scintillation counting, PGE2 release was measured by Radioimmunoassay, [3H]myo-inositol phosphates production was measured by ion-exchange chromatography, and PLC-beta1 expression was monitored by Western blot using antibodies specific for PLC-beta1. Results:Both n-HCM and g-HCM cells exhibited similar morphological characteristics and immunoreactivities. The effects of the agonists on AA release in both n-HCM and g-HCM cells were in the following order: PGF2alpha ≷ ET-1 ≷ CCh, their effects on PGE2 release were in the following order: PGF2alpha ≷ CCh ≷ ET-1, and their effects on inositol phosphates production were in the following order CCh ≷ ET-1 ≷ PGF2alpha . The data obtained can be summarized as follows: (a) Both the basal- and stimulated release of AA is significantly higher in the g-HCM cells than in the n-HCM cells, (b) the basal release of PGE2 in g-HCM cells is 2-5 fold higher than that of n-HCM cells, (c) agonist-induced inositol phosphates production in g-HCM cells is considerably lower than that of n-HCM cells, and (d) the amount of phospholipase C-beta1 (PLC-beta1) expressed in g-HCM cells, as compared to n-HCM cells, is markedly reduced. Conclusion: These data are the first to show that basal and agonists-induced AA release and inositol phosphates production as well as expression of PLC-beta1 are altered in g-HCM cells as compared to n-HCM cells. Comparative studies on the signaling pathways in g-HCM and n-HCM cells may provide important information about the regulation of uveoscleral outflow and glaucoma pathology.

Keywords: 577 second messengers: pharmacology/physiology • 392 eicosanoids • 348 ciliary body 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×